Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.095 | 0.6 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |